Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
March Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
March Biosciences

March Biosciences

March Biosciences, a Houston-based software firm, develops CAR-T cell strategies for hematological cancers.

HQ
Houston, TX, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

March Biosciences, founded in Houston, Texas, is a clinical-stage company dedicated to advancing cell therapy solutions for hematological cancers. Their core mission is to transform patient care by developing innovative CAR-T cell strategies that target the most challenging blood cancers. The company's flagship product, MB-105, is a CD5 CAR T-cell therapy currently in clinical development for treating T-cell lymphoma.

Key figures associated with March Biosciences include leading researchers and clinicians in the field of cell therapy. The company has garnered attention for its promising pipeline and has made significant strides in clinical trials, positioning itself as a pioneer in CAR-T cell therapy. March Biosciences' impact is evident in its potential to revolutionize treatment options for patients with hematological cancers, offering new hope where traditional therapies have failed.

March Biosciences - Similar Companies

Mongoose Bio logo

Mongoose Bio

mongoosebio.com

3T Biosciences logo

3T Biosciences

3tbiosciences.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

MBX Biosciences logo

MBX Biosciences

mbxbio.com

ManaT Bio logo

ManaT Bio

clasptx.com

Trailhead Biosystems logo

Trailhead Biosystems

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

MonarchBio logo

MonarchBio

monarch-bio.com

Sporos Bioventures logo

Sporos Bioventures

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Tr1x logo

Tr1x

tr1x.bio

Aleta Biotherapeutics logo

Aleta Biotherapeutics

aletabio.com

Minerva Biotechnologies logo

Minerva Biotechnologies

minervabio.com

Marengo Therapeutics logo

Marengo Therapeutics

marengotx.com

March Biosciences - Quick Facts

Who are March Biosciences' competitors?

Companies similar to March Biosciences include Mongoose Bio, 3T Biosciences, Immpact Bio and MBX Biosciences.

When was March Biosciences founded?

March Biosciences was founded in 2021.

Where is March Biosciences' headquarters located?

March Biosciences' headquarters is located in Houston, TX, US.

When was March Biosciences' last funding round?

March Biosciences' most recent funding round was for $13.4M (USD) in November 2023.

How much has March Biosciences raised to-date?

As of Nov 15, 2023, March Biosciences has raised a total of $18.2M (USD).

How many employees does March Biosciences have?

March Biosciences has 7 employees as of Feb 5, 2024.

March Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Cell Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research